Published :
Tables : 46
Figures : 43
Category : Healthcare
No. of Pages : 216
Report Code : HC-1146
Levothyroxine market is projected to achieve a CAGR of over 4% from the forecast period 2022 to 2028. Levothyroxine acts as an analogue hormone that is used to replace the hormone in patients who are suffering from a thyroid issue. The rising awareness regarding hypothyroidism is propelling the market. The rise in the number of drugs used to diagnose hypothyroidism is driving the growth of the market. The rising number of thyroid disorder and thyroid cancer issue has also boosted the market. The market is bifurcated into type, disease indication, distribution channel and by region. Based on disease indication, hypothyroidism is forecasted to witness substantial growth. Hypothyroidism is the most common thyroid disorder. Iodine deficiency holds a huge majority of hypothyroidism cases. According to research reports, about one-third of the global population lives in iodine-deficient areas and its consequences could cause hypothyroidism and growth disorders. This has resulted in the growing demand for levothyroxine, thus accelerating the growth of the market. The imposition of new thyroid function testing has resulted in a spike in prescriptions of levothyroxine to diagnose hypothyroidism. In terms of type, intravenous injection is said to have substantial growth. Increasing R&D is set to boost the demand for intravenous injection, thus elevating the market. In terms of distribution channel, hospital pharmacies are expected to dictate the market. Developed healthcare infrastructure in developed economies is driving its growth. Hospital pharmacies have experienced personnel who supply diagnose hypothyroidism as per the requirement. Online pharmacies are also expected to show significant growth during the forecast period. Expansion of e-commerce is expected to have a positive influence on online pharmacy. In terms of region, North America is the global leader of the market. According to the American Thyroid Association report, approximately 12% of the U.S. population will develop a thyroid condition during their lifetime and an approximate amount of 20 million Americans are diagnosed with some form of thyroid disease during their lifetime. Asia-Pacific region is also expected to be a lucrative region for manufacturers. Rising disposable income alongside developed health infrastructure is promoting the market in the region. The large patient population in developing economies like India and China is driving the growth of the market. The imposition of favorable policies by the government is also escalating the growth of the market in the region. Additional Insights: The ATA has confirmed that levothyroxine sodium is the most preferred choice of treatment for hypothyroidism. India and China are major markets for levothyroxine drugs. Established players of the market are Abbott Ltd, Alara Pharm (Sandoz), Forest (Actavis), Merck Serono, Piramal Healthcare, Mylan, KING PHARMS R AND D and Jerome Stevens. Levothyroxine Market Segmentation: By Disease Indication Hypothyroidism Goiter Thyroid Cancer Myxedema Coma By Type Tablet Intravenous Injection By Distribution Channel Hospital Pharmacy Retail Pharmacy Online Pharmacy By Region North America Latin America Europe Asia-Pacific Middle East and Africa Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Key Takeaways Mergers and acquisitions of a prominent player are also propelling the market. The merging of Amneal with Jerome Stevens Pharmaceuticals Inc. has strengthened the company's presence in North America. Objectives of the Study: To provide with an exhaustive analysis on the global levothyroxine market based on disease indication, distribution type, type, and region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and rest of the world To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers, and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization services offered are free of charge with purchase of any license of the report. You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Levothyroxine acts as an analogue hormone that is used to replace the hormone in patients who are suffering from a thyroid issue. The rising awareness regarding hypothyroidism is propelling the market. The rise in the number of drugs used to diagnose hypothyroidism is driving the growth of the market. The rising number of thyroid disorder and thyroid cancer issue has also boosted the market.
The market is bifurcated into type, disease indication, distribution channel and by region. Based on disease indication, hypothyroidism is forecasted to witness substantial growth. Hypothyroidism is the most common thyroid disorder. Iodine deficiency holds a huge majority of hypothyroidism cases. According to research reports, about one-third of the global population lives in iodine-deficient areas and its consequences could cause hypothyroidism and growth disorders. This has resulted in the growing demand for levothyroxine, thus accelerating the growth of the market. The imposition of new thyroid function testing has resulted in a spike in prescriptions of levothyroxine to diagnose hypothyroidism.
In terms of type, intravenous injection is said to have substantial growth. Increasing R&D is set to boost the demand for intravenous injection, thus elevating the market.
In terms of distribution channel, hospital pharmacies are expected to dictate the market. Developed healthcare infrastructure in developed economies is driving its growth. Hospital pharmacies have experienced personnel who supply diagnose hypothyroidism as per the requirement. Online pharmacies are also expected to show significant growth during the forecast period. Expansion of e-commerce is expected to have a positive influence on online pharmacy.
In terms of region, North America is the global leader of the market. According to the American Thyroid Association report, approximately 12% of the U.S. population will develop a thyroid condition during their lifetime and an approximate amount of 20 million Americans are diagnosed with some form of thyroid disease during their lifetime. Asia-Pacific region is also expected to be a lucrative region for manufacturers. Rising disposable income alongside developed health infrastructure is promoting the market in the region. The large patient population in developing economies like India and China is driving the growth of the market. The imposition of favorable policies by the government is also escalating the growth of the market in the region.
Additional Insights:
The ATA has confirmed that levothyroxine sodium is the most preferred choice of treatment for hypothyroidism. India and China are major markets for levothyroxine drugs.
Established players of the market are Abbott Ltd, Alara Pharm (Sandoz), Forest (Actavis), Merck Serono, Piramal Healthcare, Mylan, KING PHARMS R AND D and Jerome Stevens.
Levothyroxine Market Segmentation:
By Disease Indication
By Type
By Distribution Channel
By Region
Competitive Landscape:
FutureWise Key Takeaways
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Levothyroxine Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Levothyroxine Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Levothyroxine Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Levothyroxine Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Hypothyroidism 7.2. Goiter 7.3. Thyroid Cancer 7.4. Myxedema Coma 8. Levothyroxine Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Tablet 8.2. Intravenous Injection 9. Levothyroxine Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Hospital Pharmacy 9.2. Retail Pharmacy 9.3. Online Pharmacy 10. North America Levothyroxine Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Levothyroxine Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Levothyroxine Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Levothyroxine Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. Shenzhen LA Lighting Company Limited 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Ziphearing 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Austar Hearing Science and Technology Co., Ltd. 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Resound 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Sound world solution 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. SoundHawk 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Foshan Vohom Technology Co.Ltd. 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Levothyroxine Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Levothyroxine Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Levothyroxine Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Levothyroxine Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Hypothyroidism 7.2. Goiter 7.3. Thyroid Cancer 7.4. Myxedema Coma
8. Levothyroxine Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Tablet 8.2. Intravenous Injection
9. Levothyroxine Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Hospital Pharmacy 9.2. Retail Pharmacy 9.3. Online Pharmacy
10. North America Levothyroxine Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028
11. Latin America Levothyroxine Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028
12. Europe Levothyroxine Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028
13. Asia Pacific Levothyroxine Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028
15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. Shenzhen LA Lighting Company Limited 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Ziphearing 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Austar Hearing Science and Technology Co., Ltd. 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Resound 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Sound world solution 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. SoundHawk 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Foshan Vohom Technology Co.Ltd. 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview
17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics